January 27, 2015 7:49 AM ET


Company Overview of SpringLeaf Therapeutics, Inc.

Company Overview

SpringLeaf Therapeutics, Inc. develops drug delivery technologies. It develops and manufactures a drug delivery system called the "patch pump" to deliver drugs subcutaneously. SpringLeaf Therapeutics, Inc. was formerly known as Entra Pharmaceuticals, Inc. and changed its name to SpringLeaf Therapeutics, Inc. in March 2011. The company was incorporated in 2007 and is based in Boston, Massachusetts.

8 Saint Mary's Street

Suite 601

Boston, MA 02215

United States

Founded in 2007





Key Executives for SpringLeaf Therapeutics, Inc.

Chief Executive Officer
Age: 56
Co-Founder and Vice President of Product Development
Age: 54
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Catalent Pharma Solutions, LLC United States
Expressive Constructs, Inc. United States
Xetrios Therapeutics, Inc. United States
Reaction Biotechnology Corporation United States
Agilvax, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SpringLeaf Therapeutics, Inc., please visit www.springleaftx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.